Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01429467
What this trial is testing

Glucose Variability in Type 1 Diabetes and Its Effect on Factors That Influence New Vessel Formation

Who this might be right for
Type 1 Diabetes
University of Dundee 35
Large-scale testing (Phase 3)Ended earlyNCT06038539
What this trial is testing

Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer

Who this might be right for
HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
Biocon Biologics UK Ltd 55
Not applicableWithdrawnNCT00985036
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients

Who this might be right for
GliomaMeningioma
Marquette General Health System
Not applicableStudy completedNCT04035811
What this trial is testing

Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)

Who this might be right for
Achondroplasia
QED Therapeutics, a BridgeBio company 271
Not applicableLooking for participantsNCT06929507
What this trial is testing

Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients

Who this might be right for
Renal Function DisorderDiabetic Macular Edema (DME)Neovascular Age Related Macular Degeneration
University Hospital, Alexandroupolis 60
Large-scale testing (Phase 3)Active Not RecruitingNCT03734029
What this trial is testing

Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

Who this might be right for
Breast Cancer
Daiichi Sankyo 557
Not applicableStudy completedNCT01791712
What this trial is testing

Efficacy of Online Hemodiafiltrationlysis in Cytokine Removal

Who this might be right for
SepsisAcute Kidney Injury
Chulalongkorn University 28
Early research (Phase 1)Study completedNCT00040781
What this trial is testing

Gefitinib in Treating Children With Refractory Solid Tumors

Who this might be right for
Unspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 45
Early research (Phase 1)Not Yet RecruitingNCT06585059
What this trial is testing

Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers

Who this might be right for
Advanced Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 20
Not applicableLooking for participantsNCT05573893
What this trial is testing

PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan

Who this might be right for
Breast NeoplasmsBreast CancerNeoplasm Metastasis
AstraZeneca 800
Testing effectiveness (Phase 2)Ended earlyNCT03510455
What this trial is testing

BGJ398 for the Treatment of Tumor-Induced Osteomalacia

Who this might be right for
Tumor-Induced OsteomalaciaOncogenic Osteomalacia
National Institute of Dental and Craniofacial Research (NIDCR) 4
Early research (Phase 1)Study completedNCT00372515
What this trial is testing

High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations

Who this might be right for
Non-Small Cell Lung Cancer
David M. Jackman, MD 7
Early research (Phase 1)Ended earlyNCT06264921
What this trial is testing

A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more
NiKang Therapeutics, Inc. 23
Large-scale testing (Phase 3)Looking for participantsNCT06712355
What this trial is testing

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
BioNTech SE 621
Early research (Phase 1)Study completedNCT01005355
What this trial is testing

Study of IMC-1121B in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Eli Lilly and Company 15
Not applicableStudy completedNCT03263884
What this trial is testing

Repetitive Transcranial Magnetic Stimulation and the Development of Ongoing Muscle Pain

Who this might be right for
Pain Relief
Aalborg University 30
Not applicableStudy completedNCT00966134
What this trial is testing

Ghrelin, Growth Hormone and Growth Factors at High Altitude

Who this might be right for
HealthyGrowth Hormone
Medical University of Vienna
Not applicableStudy completedNCT00136032
What this trial is testing

Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women

Who this might be right for
Growth Hormone Deficiency
Massachusetts General Hospital 63
Testing effectiveness (Phase 2)Study completedNCT03560531
What this trial is testing

ZN-c5 in Subjects With Breast Cancer

Who this might be right for
Breast Cancer
Zeno Alpha Inc. 181
Early research (Phase 1)Ended earlyNCT00783172
What this trial is testing

Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Milton S. Hershey Medical Center 4
Next Page